Clinical Trials › NCT07067463
RecruitingPhase 3
A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis
Sponsored by Zenas BioPharma (USA), LLC
Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov 705
Target enrollment
2
U.S. states
Dec 2025
Start date
Jul 2030
Expected completion
Interventions / Treatments
OrelabrutinibPlacebo
Conditions studied
Multiple Sclerosis (MS) Primary Progressive
Where this trial is running (2 sites)
Florida1 site
Maitland
South Carolina1 site
Greenville
Participating MS centers on MS Buddy (1)
Premier Neurology, PC
Greenville, SC
Greenville, SC
MS centers in Florida
Compare treatment centers near a trial site by center type, providers and trials.
View Florida centersMore Phase 3 trials
Browse all Phase 3 MS trialsThe app
Check out the MS Buddy app
Track symptoms, monitor wellness, and stay on top of your MS care. It’s free, with no ads. Built by people living with MS.